Enrico Bronte

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24).

Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24).

Journal: European urology open science

Published: September 28, 2025

Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study.

Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study.

Journal: The oncologist

Published: July 30, 2025

Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.

Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study.

Journal: Liver cancer

Published: April 29, 2025

The Association Between Hepatocellular Carcinoma and Gastrointestinal Adenocarcinoma: Is This a New Syndrome in Patients With Cirrhosis? A Case Series.

The Association Between Hepatocellular Carcinoma and Gastrointestinal Adenocarcinoma: Is This a New Syndrome in Patients With Cirrhosis? A Case Series.

Journal: Cancer reports (Hoboken, N.J.)

Published: October 07, 2024

The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE).

The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE).

Journal: Current oncology (Toronto, Ont.)

Published: January 11, 2024

Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience.

Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience.

Journal: Oncology

Published: October 27, 2019

Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.

Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer.

Journal: Translational cancer research

Published: August 09, 2018

Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors.

Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors.

Journal: Pharmacology & therapeutics

Published: July 03, 2018

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.

Journal: Biological reviews of the Cambridge Philosophical Society

Published: September 01, 2017

Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.

Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.

Journal: Current cancer drug targets

Published: May 12, 2017

Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond.

Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond.

Journal: International journal of cardiology

Published: September 02, 2016

What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment.

What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment.

Journal: Oncotarget

Published: August 04, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026